US Stock MarketDetailed Quotes

BRTH Breathe BioMedical

Watchlist
  • 0.000
  • 0.0000.00%
Close Feb 27 09:30 ET
0Market Cap0.00P/E (TTM)

Breathe BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
164.61%3.53M
75.40%8.9M
1.33M
11.41%5.07M
4.55M
Selling and administrative expenses
338.18%2.85M
101.89%6.7M
--650.6K
2.67%3.32M
--3.23M
-Selling and marketing expense
-99.27%89
-4.89%61.61K
--12.23K
-58.51%64.77K
--156.11K
-General and administrative expense
346.55%2.85M
104.02%6.64M
--638.37K
5.78%3.25M
--3.08M
Research and development costs
-9.34%571.35K
14.61%2.09M
--630.21K
13.91%1.82M
--1.6M
Depreciation amortization depletion
43.18%132.85K
47.13%383.26K
--92.79K
18.06%260.48K
--220.63K
-Depreciation and amortization
43.18%132.85K
47.13%383.26K
--92.79K
18.06%260.48K
--220.63K
Other operating expenses
35.41%-25.76K
17.18%-271.5K
---39.87K
34.29%-327.83K
---498.91K
Operating profit
-164.61%-3.53M
-75.40%-8.9M
-1.33M
-11.41%-5.07M
-4.55M
Net non-operating interest income expense
-323.87%-10.6K
-211.55%-16.15K
4.73K
19.46%14.48K
12.12K
Total other finance cost
323.87%10.6K
211.55%16.15K
---4.73K
-19.46%-14.48K
---12.12K
Other net income (expense)
18.76%203.85K
-7.82%555K
171.65K
5.27%602.07K
571.95K
Gain on sale of security
16.92%5.6K
-166.07%-4.27K
--4.79K
-53.24%6.46K
--13.82K
Other non- operating income (expenses)
18.81%198.25K
-6.10%559.27K
--166.86K
6.71%595.6K
--558.13K
Income before tax
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Income tax
0
0
0
0
0
Net income
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Net income continuous Operations
-188.25%-3.34M
-87.57%-8.36M
---1.16M
-12.28%-4.46M
---3.97M
Minority interest income
Net income attributable to the parent company
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-188.25%-3.34M
-87.57%-8.36M
-1.16M
-12.28%-4.46M
-3.97M
Basic earnings per share
-188.25%-0.3056
-87.57%-0.7661
-0.106
-12.28%-0.4085
-0.3638
Diluted earnings per share
-188.25%-0.3056
-87.57%-0.7661
-0.106
-12.28%-0.4085
-0.3638
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 164.61%3.53M75.40%8.9M1.33M11.41%5.07M4.55M
Selling and administrative expenses 338.18%2.85M101.89%6.7M--650.6K2.67%3.32M--3.23M
-Selling and marketing expense -99.27%89-4.89%61.61K--12.23K-58.51%64.77K--156.11K
-General and administrative expense 346.55%2.85M104.02%6.64M--638.37K5.78%3.25M--3.08M
Research and development costs -9.34%571.35K14.61%2.09M--630.21K13.91%1.82M--1.6M
Depreciation amortization depletion 43.18%132.85K47.13%383.26K--92.79K18.06%260.48K--220.63K
-Depreciation and amortization 43.18%132.85K47.13%383.26K--92.79K18.06%260.48K--220.63K
Other operating expenses 35.41%-25.76K17.18%-271.5K---39.87K34.29%-327.83K---498.91K
Operating profit -164.61%-3.53M-75.40%-8.9M-1.33M-11.41%-5.07M-4.55M
Net non-operating interest income expense -323.87%-10.6K-211.55%-16.15K4.73K19.46%14.48K12.12K
Total other finance cost 323.87%10.6K211.55%16.15K---4.73K-19.46%-14.48K---12.12K
Other net income (expense) 18.76%203.85K-7.82%555K171.65K5.27%602.07K571.95K
Gain on sale of security 16.92%5.6K-166.07%-4.27K--4.79K-53.24%6.46K--13.82K
Other non- operating income (expenses) 18.81%198.25K-6.10%559.27K--166.86K6.71%595.6K--558.13K
Income before tax -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Income tax 00000
Net income -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Net income continuous Operations -188.25%-3.34M-87.57%-8.36M---1.16M-12.28%-4.46M---3.97M
Minority interest income
Net income attributable to the parent company -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -188.25%-3.34M-87.57%-8.36M-1.16M-12.28%-4.46M-3.97M
Basic earnings per share -188.25%-0.3056-87.57%-0.7661-0.106-12.28%-0.4085-0.3638
Diluted earnings per share -188.25%-0.3056-87.57%-0.7661-0.106-12.28%-0.4085-0.3638
Dividend per share
Currency Unit CADCADCADCADCAD

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+20.86%
Ji Yao Holding Group
300108
+20.22%
4
Sino Geophysical
300191
+20.03%
5
Henan Carve Electronics Technology
301182
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.